Back to search
FDAFDA · Food and drugs·Recall number D-1226-2022

Sermorelin 2000mcg/mL, 7.5mL-vial, Refrigerate, Tailor Made Compounding

Published July 20, 2022 · Recall initiated: March 7, 2022

Summary

FDA records drug Class II recall D-1226-2022, published July 20, 2022 and initiated March 7, 2022. Recalling firm: TMC Acquisition LLC dba Tailor Made Compounding; Status: Ongoing; Reported quantity: 1,208 vials; Lot: Batch#: 10122103A2, Exp 3/22/2022; 11092108A2, Exp 4/30/2022; 11192115A2, Exp 5/7/2022; 12022107A2, Exp 5/22/2022; 12132107A2, Exp 5/24/2022; 01182201A2, Exp 6/30/2022; 02142212A1, Exp 8/13/2022; 03022217A1, Exp 8/29/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
TMC Acquisition LLC dba Tailor Made Compounding
Distributor
Nationwide USA and Puerto Rico
Lot
Batch#: 10122103A2, Exp 3/22/2022; 11092108A2, Exp 4/30/2022; 11192115A2, Exp 5/7/2022; 12022107A2, Exp 5/22/2022; 12132107A2, Exp 5/24/2022; 01182201A2, Exp 6/30/2022; 02142212A1, Exp 8/13/2022; 03022217A1, Exp 8/29/2022.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sermorelin 2000mcg/mL, 7.5mL-vial, Refrigerate, Tailor Made Compounding recalled?

Yes. FDA published recall D-1226-2022 on July 20, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter